Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Cannon

Showing results (331-340 of 706) with videos related to

Pageof 71
Sort By:
Diabetes, Obesity & Metabolism|March 2, 2022
The differential effects of ertugliflozin on glucosuria and natriuresis biomarkers: Prespecified analyses from VERTIS CVDavid Z I Cherney, Francesco Cosentino, Richard E Pratley, et al.
Journal of Interventional Cardiology|April 24, 2004
Timing of angiography and revascularization in acute coronary syndromes: an analysis of the TACTICS-TIMI-18 trialPeter A McCullough, C Michael Gibson, Peter M Dibattiste, et al.
Journal of the American College of Cardiology|February 1, 2005
Association of a negative residual stenosis following rescue/adjunctive percutaneous coronary intervention with impaired myocardial perfusion and adverse outcomes among ST-segment elevation myocardial infarction patientsC Michael Gibson, Ajay J Kirtane, Keith Boundy, et al.
Clinical Cardiology|May 20, 2008
Antiplatelet strategies: evaluating their current role in the setting of acute coronary syndromesEugene Braunwald, Dominick Angiolillo, Eric Bates, et al.
Clinical Cardiology|May 20, 2008
Investigating the mechanisms of hyporesponse to antiplatelet approachesEugene Braunwald, Dominick Angiolillo, Eric Bates, et al.
Journal of the American College of Cardiology|November 6, 2007
Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromesRobert F Storey, Steen Husted, Robert A Harrington, et al.
American Heart Journal|February 5, 2025
Rationale, design and prerandomization data for a cluster randomized trial to assess the effect of a digitally enabled quality improvement intervention on LDL-C control in established atherosclerotic cardiovascular disease patients: The SAPPHIRE-LDL trialM Julia Machline-Carrion, Alysson Nathan Girotto, Priscila Raupp, et al.
Journal of the American Heart Association|February 3, 2022
Cardiovascular Events and Long-Term Risk of Sudden Death Among Stabilized Patients After Acute Coronary Syndrome: Insights From IMPROVE-ITChristopher B Fordyce, Robert P Giugliano, Christopher P Cannon, et al.
The American Journal of Cardiology|October 15, 2003
Evaluation of the association of proximal coronary culprit artery lesion location with clinical outcomes in acute myocardial infarctionJuhana Karha, Sabina A Murphy, Ajay J Kirtane, et al.
Journal of the American College of Cardiology|August 18, 2004
Performance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4: a simple index that predicts mortality in ST-segment elevation myocardial infarctionStephen D Wiviott, David A Morrow, Paul D Frederick, et al.
Pageof 71

Showing results (331-340 of 706) with videos related to

Sort By:
Pageof 71
Diabetes, Obesity & Metabolism|March 2, 2022
The differential effects of ertugliflozin on glucosuria and natriuresis biomarkers: Prespecified analyses from VERTIS CVDavid Z I Cherney, Francesco Cosentino, Richard E Pratley, et al.
Journal of Interventional Cardiology|April 24, 2004
Timing of angiography and revascularization in acute coronary syndromes: an analysis of the TACTICS-TIMI-18 trialPeter A McCullough, C Michael Gibson, Peter M Dibattiste, et al.
Journal of the American College of Cardiology|February 1, 2005
Association of a negative residual stenosis following rescue/adjunctive percutaneous coronary intervention with impaired myocardial perfusion and adverse outcomes among ST-segment elevation myocardial infarction patientsC Michael Gibson, Ajay J Kirtane, Keith Boundy, et al.
Clinical Cardiology|May 20, 2008
Antiplatelet strategies: evaluating their current role in the setting of acute coronary syndromesEugene Braunwald, Dominick Angiolillo, Eric Bates, et al.
Clinical Cardiology|May 20, 2008
Investigating the mechanisms of hyporesponse to antiplatelet approachesEugene Braunwald, Dominick Angiolillo, Eric Bates, et al.
Journal of the American College of Cardiology|November 6, 2007
Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromesRobert F Storey, Steen Husted, Robert A Harrington, et al.
American Heart Journal|February 5, 2025
Rationale, design and prerandomization data for a cluster randomized trial to assess the effect of a digitally enabled quality improvement intervention on LDL-C control in established atherosclerotic cardiovascular disease patients: The SAPPHIRE-LDL trialM Julia Machline-Carrion, Alysson Nathan Girotto, Priscila Raupp, et al.
Journal of the American Heart Association|February 3, 2022
Cardiovascular Events and Long-Term Risk of Sudden Death Among Stabilized Patients After Acute Coronary Syndrome: Insights From IMPROVE-ITChristopher B Fordyce, Robert P Giugliano, Christopher P Cannon, et al.
The American Journal of Cardiology|October 15, 2003
Evaluation of the association of proximal coronary culprit artery lesion location with clinical outcomes in acute myocardial infarctionJuhana Karha, Sabina A Murphy, Ajay J Kirtane, et al.
Journal of the American College of Cardiology|August 18, 2004
Performance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4: a simple index that predicts mortality in ST-segment elevation myocardial infarctionStephen D Wiviott, David A Morrow, Paul D Frederick, et al.
Pageof 71